Substantia Nigra D1Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism
Open Access
- 1 November 1997
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 17 (21) , 8498-8505
- https://doi.org/10.1523/jneurosci.17-21-08498.1997
Abstract
Dopamine release can regulate striatal acetylcholine effluxin vivo through at least two receptor mechanisms: (1) direct inhibition by dopamine D2 receptors on the cholinergic neurons, and (2) excitation initiated by dopamine D1 receptors. The neuroanatomical locus of the latter population of D1 receptors and the pathway(s) involved in the expression of their influence are controversial issues. We have tested the hypothesis that D1 receptors in substantia nigra pars reticulata are involved in the excitatory component of dopaminergic actions on striatal acetylcholine output. In vivo microdialysis was used in awake rats. Infusion of the selective D1 receptor agonistR(+)-1-Phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol (SKF 38393) hydrochloride into pars reticulata of substantia nigra elicited a significant increase in striatal acetylcholine efflux. Likewise, d-amphetamine applied into pars reticulata of substantia nigra by reverse dialysis produced an elevation in acetylcholine output measured at a second microdialysis probe in the striatum. Application of d-amphetamine in the striatum by reverse dialysis elicited a decrease in striatal acetylcholine efflux that could be reversed subsequently by local application ofd-amphetamine in substantia nigra pars reticulata. A 2 mg/kg intraperitoneal dose of d-amphetamine, which has no net effect on striatal acetylcholine output under control conditions, elicited a significant decrease in acetylcholine efflux when the D1 receptor antagonistR(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390) hydrochloride was applied simultaneously via a second microdialysis probe in substantia nigra pars reticulata. Thus, an excitatory D1-mediated influence on striatal acetylcholine output is initiated in substantia nigra pars reticulata, and this influence contributes to the effects of indirect dopaminergic agonists such as d-amphetamine on striatal acetylcholine efflux. These results indicate an important role of somatodendritic dopamine release, in addition to nerve terminal dopamine release, in the regulation of activity in basal ganglia circuits.Keywords
This publication has 56 references indexed in Scilit:
- Role of NMDA, AMPA and kainate receptors in mediating glutamate- and 4-AP-induced dopamine and acetylcholine release from rat striatal slicesNeuropharmacology, 1994
- GABAA and GABAB receptors differentially regulate striatal acetylcholine release in vivoNeuroscience Letters, 1993
- Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behaviorBrain Research, 1993
- D2 dopamine receptor gene expression by cholinergic neurons in the rat striatumNeuroscience Letters, 1990
- Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the ratNeuroscience Letters, 1990
- Interaction of the D1Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP SyndromeJournal of Receptor Research, 1988
- 3H-SCH 23390 binding sites in the rat substantia nigra: Evidence for a presynaptic localization and innervation by dopamineLife Sciences, 1986
- Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390Brain Research, 1986
- Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmissionLife Sciences, 1982
- Dopamine release in substantia nigra?Nature, 1976